List of Tables
Table 1. Global Acute Hyperammonemia Treatment Drugs Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Acute Hyperammonemia Treatment Drugs Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Acute Hyperammonemia Treatment Drugs Market Competitive Situation by Manufacturers in 2025
Table 4. Global Acute Hyperammonemia Treatment Drugs Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Acute Hyperammonemia Treatment Drugs Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Acute Hyperammonemia Treatment Drugs Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Acute Hyperammonemia Treatment Drugs Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Acute Hyperammonemia Treatment Drugs Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Acute Hyperammonemia Treatment Drugs, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Acute Hyperammonemia Treatment Drugs, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Acute Hyperammonemia Treatment Drugs, Product Types and Applications
Table 12. Global Key Manufacturers of Acute Hyperammonemia Treatment Drugs, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Acute Hyperammonemia Treatment Drugs Companies by Tier (Tier 1, Tier 2, Tier 3), based on Acute Hyperammonemia Treatment Drugs Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Acute Hyperammonemia Treatment Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Acute Hyperammonemia Treatment Drugs Sales by Region (K Units), 2021–2026
Table 18. Global Acute Hyperammonemia Treatment Drugs Sales Market Share by Region (2021–2026)
Table 19. Global Acute Hyperammonemia Treatment Drugs Sales by Region (K Units), 2027–2032
Table 20. Global Acute Hyperammonemia Treatment Drugs Sales Market Share by Region (2027–2032)
Table 21. Global Acute Hyperammonemia Treatment Drugs Revenue by Region (US$ Million), 2021–2026
Table 22. Global Acute Hyperammonemia Treatment Drugs Revenue Market Share by Region (2021–2026)
Table 23. Global Acute Hyperammonemia Treatment Drugs Revenue by Region (US$ Million), 2027–2032
Table 24. Global Acute Hyperammonemia Treatment Drugs Revenue Market Share by Region (2027–2032)
Table 25. North America Acute Hyperammonemia Treatment Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Acute Hyperammonemia Treatment Drugs Sales by Country (K Units), 2021–2026
Table 27. North America Acute Hyperammonemia Treatment Drugs Sales by Country (K Units), 2027–2032
Table 28. North America Acute Hyperammonemia Treatment Drugs Revenue by Country (US$ Million), 2021–2026
Table 29. North America Acute Hyperammonemia Treatment Drugs Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Acute Hyperammonemia Treatment Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Acute Hyperammonemia Treatment Drugs Sales by Country (K Units), 2021–2026
Table 32. Europe Acute Hyperammonemia Treatment Drugs Sales by Country (K Units), 2027–2032
Table 33. Europe Acute Hyperammonemia Treatment Drugs Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Acute Hyperammonemia Treatment Drugs Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Acute Hyperammonemia Treatment Drugs Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Acute Hyperammonemia Treatment Drugs Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Acute Hyperammonemia Treatment Drugs Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Acute Hyperammonemia Treatment Drugs Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Acute Hyperammonemia Treatment Drugs Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Acute Hyperammonemia Treatment Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Acute Hyperammonemia Treatment Drugs Sales by Country (K Units), 2021–2026
Table 42. Latin America Acute Hyperammonemia Treatment Drugs Sales by Country (K Units), 2027–2032
Table 43. Latin America Acute Hyperammonemia Treatment Drugs Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Acute Hyperammonemia Treatment Drugs Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Acute Hyperammonemia Treatment Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Acute Hyperammonemia Treatment Drugs Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Acute Hyperammonemia Treatment Drugs Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Acute Hyperammonemia Treatment Drugs Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Acute Hyperammonemia Treatment Drugs Revenue by Country (US$ Million), 2027–2032
Table 50. Global Acute Hyperammonemia Treatment Drugs Sales (K Units) by Type (2021–2026)
Table 51. Global Acute Hyperammonemia Treatment Drugs Sales (K Units) by Type (2027–2032)
Table 52. Global Acute Hyperammonemia Treatment Drugs Sales Market Share by Type (2021–2026)
Table 53. Global Acute Hyperammonemia Treatment Drugs Sales Market Share by Type (2027–2032)
Table 54. Global Acute Hyperammonemia Treatment Drugs Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Acute Hyperammonemia Treatment Drugs Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Acute Hyperammonemia Treatment Drugs Revenue Market Share by Type (2021–2026)
Table 57. Global Acute Hyperammonemia Treatment Drugs Revenue Market Share by Type (2027–2032)
Table 58. Global Acute Hyperammonemia Treatment Drugs Price (US$/Unit) by Type (2021–2026)
Table 59. Global Acute Hyperammonemia Treatment Drugs Price (US$/Unit) by Type (2027–2032)
Table 60. Global Acute Hyperammonemia Treatment Drugs Sales (K Units) by Application (2021–2026)
Table 61. Global Acute Hyperammonemia Treatment Drugs Sales (K Units) by Application (2027–2032)
Table 62. Global Acute Hyperammonemia Treatment Drugs Sales Market Share by Application (2021–2026)
Table 63. Global Acute Hyperammonemia Treatment Drugs Sales Market Share by Application (2027–2032)
Table 64. Global Acute Hyperammonemia Treatment Drugs Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Acute Hyperammonemia Treatment Drugs Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Acute Hyperammonemia Treatment Drugs Revenue Market Share by Application (2021–2026)
Table 67. Global Acute Hyperammonemia Treatment Drugs Revenue Market Share by Application (2027–2032)
Table 68. Global Acute Hyperammonemia Treatment Drugs Price (US$/Unit) by Application (2021–2026)
Table 69. Global Acute Hyperammonemia Treatment Drugs Price (US$/Unit) by Application (2027–2032)
Table 70. Lee's Pharmaceutical Company Information
Table 71. Lee's Pharmaceutical Description and Business Overview
Table 72. Lee's Pharmaceutical Acute Hyperammonemia Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Lee's Pharmaceutical Acute Hyperammonemia Treatment Drugs Product
Table 74. Lee's Pharmaceutical Recent Developments/Updates
Table 75. Medunik Company Information
Table 76. Medunik Description and Business Overview
Table 77. Medunik Acute Hyperammonemia Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Medunik Acute Hyperammonemia Treatment Drugs Product
Table 79. Medunik Recent Developments/Updates
Table 80. Sigmapharm Laboratories Company Information
Table 81. Sigmapharm Laboratories Description and Business Overview
Table 82. Sigmapharm Laboratories Acute Hyperammonemia Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Sigmapharm Laboratories Acute Hyperammonemia Treatment Drugs Product
Table 84. Sigmapharm Laboratories Recent Developments/Updates
Table 85. Amgen Company Information
Table 86. Amgen Description and Business Overview
Table 87. Amgen Acute Hyperammonemia Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Amgen Acute Hyperammonemia Treatment Drugs Product
Table 89. Amgen Recent Developments/Updates
Table 90. Acer Therapeutics Company Information
Table 91. Acer Therapeutics Description and Business Overview
Table 92. Acer Therapeutics Acute Hyperammonemia Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Acer Therapeutics Acute Hyperammonemia Treatment Drugs Product
Table 94. Acer Therapeutics Recent Developments/Updates
Table 95. Immedica Company Information
Table 96. Immedica Description and Business Overview
Table 97. Immedica Acute Hyperammonemia Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Immedica Acute Hyperammonemia Treatment Drugs Product
Table 99. Immedica Recent Developments/Updates
Table 100. Recordati Company Information
Table 101. Recordati Description and Business Overview
Table 102. Recordati Acute Hyperammonemia Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Recordati Acute Hyperammonemia Treatment Drugs Product
Table 104. Recordati Recent Developments/Updates
Table 105. Ultragenyx Pharmaceutical Company Information
Table 106. Ultragenyx Pharmaceutical Description and Business Overview
Table 107. Ultragenyx Pharmaceutical Acute Hyperammonemia Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Ultragenyx Pharmaceutical Acute Hyperammonemia Treatment Drugs Product
Table 109. Ultragenyx Pharmaceutical Recent Developments/Updates
Table 110. Spyre Therapeutics Company Information
Table 111. Spyre Therapeutics Description and Business Overview
Table 112. Spyre Therapeutics Acute Hyperammonemia Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Spyre Therapeutics Acute Hyperammonemia Treatment Drugs Product
Table 114. Spyre Therapeutics Recent Developments/Updates
Table 115. Arcturus Therapeutics Company Information
Table 116. Arcturus Therapeutics Description and Business Overview
Table 117. Arcturus Therapeutics Acute Hyperammonemia Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Arcturus Therapeutics Acute Hyperammonemia Treatment Drugs Product
Table 119. Arcturus Therapeutics Recent Developments/Updates
Table 120. Orpharma Company Information
Table 121. Orpharma Description and Business Overview
Table 122. Orpharma Acute Hyperammonemia Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. Orpharma Acute Hyperammonemia Treatment Drugs Product
Table 124. Orpharma Recent Developments/Updates
Table 125. Abbott Laboratories Company Information
Table 126. Abbott Laboratories Description and Business Overview
Table 127. Abbott Laboratories Acute Hyperammonemia Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. Abbott Laboratories Acute Hyperammonemia Treatment Drugs Product
Table 129. Abbott Laboratories Recent Developments/Updates
Table 130. Selecta Biosciences Company Information
Table 131. Selecta Biosciences Description and Business Overview
Table 132. Selecta Biosciences Acute Hyperammonemia Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 133. Selecta Biosciences Acute Hyperammonemia Treatment Drugs Product
Table 134. Selecta Biosciences Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Acute Hyperammonemia Treatment Drugs Distributors List
Table 138. Acute Hyperammonemia Treatment Drugs Customers List
Table 139. Acute Hyperammonemia Treatment Drugs Market Trends
Table 140. Acute Hyperammonemia Treatment Drugs Market Drivers
Table 141. Acute Hyperammonemia Treatment Drugs Market Challenges
Table 142. Acute Hyperammonemia Treatment Drugs Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
Table 146. Authors List of This Report
List of Figures
Figure 1. Product Picture of Acute Hyperammonemia Treatment Drugs
Figure 2. Global Acute Hyperammonemia Treatment Drugs Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Acute Hyperammonemia Treatment Drugs Market Share by Type: 2025 & 2032
Figure 4. Sodium Phenylbutyrate Product Picture
Figure 5. Arginine Product Picture
Figure 6. Sodium Benzoate Product Picture
Figure 7. Other Product Picture
Figure 8. Global Acute Hyperammonemia Treatment Drugs Market Value by Application (US$ Million), 2021–2032
Figure 9. Global Acute Hyperammonemia Treatment Drugs Market Share by Application: 2025 & 2032
Figure 10. Hospital
Figure 11. Clinic
Figure 12. Global Acute Hyperammonemia Treatment Drugs Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global Acute Hyperammonemia Treatment Drugs Market Size (US$ Million), 2021–2032
Figure 14. Global Acute Hyperammonemia Treatment Drugs Sales (K Units), 2021–2032
Figure 15. Global Acute Hyperammonemia Treatment Drugs Average Price (US$/Unit), 2021–2032
Figure 16. Acute Hyperammonemia Treatment Drugs Report Years Considered
Figure 17. Acute Hyperammonemia Treatment Drugs Sales Share by Manufacturers in 2025
Figure 18. Global Acute Hyperammonemia Treatment Drugs Revenue Share by Manufacturers in 2025
Figure 19. Top 5 and Top 10 Global Acute Hyperammonemia Treatment Drugs Players: Market Share by Revenue in Acute Hyperammonemia Treatment Drugs in 2025
Figure 20. Acute Hyperammonemia Treatment Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 21. Global Acute Hyperammonemia Treatment Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 22. North America Acute Hyperammonemia Treatment Drugs Sales Market Share by Country (2021–2032)
Figure 23. North America Acute Hyperammonemia Treatment Drugs Revenue Market Share by Country (2021–2032)
Figure 24. United States Acute Hyperammonemia Treatment Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Canada Acute Hyperammonemia Treatment Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Europe Acute Hyperammonemia Treatment Drugs Sales Market Share by Country (2021–2032)
Figure 27. Europe Acute Hyperammonemia Treatment Drugs Revenue Market Share by Country (2021–2032)
Figure 28. Germany Acute Hyperammonemia Treatment Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. France Acute Hyperammonemia Treatment Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. U.K. Acute Hyperammonemia Treatment Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Italy Acute Hyperammonemia Treatment Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Russia Acute Hyperammonemia Treatment Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Asia Pacific Acute Hyperammonemia Treatment Drugs Sales Market Share by Region (2021–2032)
Figure 34. Asia Pacific Acute Hyperammonemia Treatment Drugs Revenue Market Share by Region (2021–2032)
Figure 35. China Acute Hyperammonemia Treatment Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Japan Acute Hyperammonemia Treatment Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. South Korea Acute Hyperammonemia Treatment Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. India Acute Hyperammonemia Treatment Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Australia Acute Hyperammonemia Treatment Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. China Taiwan Acute Hyperammonemia Treatment Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Southeast Asia Acute Hyperammonemia Treatment Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Latin America Acute Hyperammonemia Treatment Drugs Sales Market Share by Country (2021–2032)
Figure 43. Latin America Acute Hyperammonemia Treatment Drugs Revenue Market Share by Country (2021–2032)
Figure 44. Mexico Acute Hyperammonemia Treatment Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Brazil Acute Hyperammonemia Treatment Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Argentina Acute Hyperammonemia Treatment Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Colombia Acute Hyperammonemia Treatment Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Middle East and Africa Acute Hyperammonemia Treatment Drugs Sales Market Share by Country (2021–2032)
Figure 49. Middle East and Africa Acute Hyperammonemia Treatment Drugs Revenue Market Share by Country (2021–2032)
Figure 50. Turkey Acute Hyperammonemia Treatment Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Saudi Arabia Acute Hyperammonemia Treatment Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. UAE Acute Hyperammonemia Treatment Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Global Sales Market Share of Acute Hyperammonemia Treatment Drugs by Type (2021–2032)
Figure 54. Global Revenue Market Share of Acute Hyperammonemia Treatment Drugs by Type (2021–2032)
Figure 55. Global Acute Hyperammonemia Treatment Drugs Price (US$/Unit) by Type (2021–2032)
Figure 56. Global Sales Market Share of Acute Hyperammonemia Treatment Drugs by Application (2021–2032)
Figure 57. Global Revenue Market Share of Acute Hyperammonemia Treatment Drugs by Application (2021–2032)
Figure 58. Global Acute Hyperammonemia Treatment Drugs Price (US$/Unit) by Application (2021–2032)
Figure 59. Acute Hyperammonemia Treatment Drugs Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
